Information experiences, needs, and preferences of colonoscopy patients

Lee, Eugene; Shafer, Leigh Anne; Walker, John R.; Waldman, Celeste; Michaud, Valérie; Yang, Chengyue; Bernstein, Çharles N.; Hathout, Linda; Park, Jason; Sisler, Jeff; Wittmeier, Kristy; Restall, Gayle; Singh, Harminder

doi:10.1097/md.0000000000015738

“…In addition, it is difficult to perform an endoscopic evaluation when there is injury to the intestinal mucosa, a frequent problem in IBD [22][23][24] .…”

Section: Discussionmentioning

confidence: 99%

Patient knowledge of fecal calprotectin in inflammatory bowel disease (IBD): An observational study in Mexico

Maldonado-Arriaga

¹

,

Sandoval-Jiménez

²

,

Rodrı́guez-Silverio

³

et al. 2021

F1000Res

0

View full text Add to dashboard Cite

Background: Fecal calprotectin (FC) can be a valuable tool to optimize health care for patients with inflammatory bowel disease (IBD). The objective of this observational study was to determine the level of knowledge of the FC test in Mexican patients with IBD. Methods: A self-report questionnaire was distributed via Facebook to patients with IBD. The survey consisted of 15 questions in two categories: the first category assessed knowledge of IBD diagnosis, and the second category assessed knowledge of the FC test. Results: In total, 460 patients with IBD participated, of which 83.9% (386) had ulcerative colitis (UC) and 16.0% (74) had Crohn’s disease (CD). Regarding IBD diagnosis, 41.9% of participants stated that they did not know of a non-invasive test for fecal matter to identify inflammation of the colon. Regarding the FC test, 57.5% (UC) and 58.1% (CD) stated that they did not know about the test. Additionally, 65.8% (UC) and 51.3% (CD) of participants stated that they had never received the FC test and 82.6% (UC) and 77.0% (CD) recognized that the FC test was difficult to access in their medical practice. Furthermore, 66% (UC) and 52.7% (CD) of participants noted that their specialist doctor had never suggested the FC test to them, yet 89.1% (UC) and 87.8% (CD) stated that they would prefer FC analysis for their IBD follow-up assessments. Conclusions: There is little knowledge of the FC biomarker among Mexican patients with IBD. This suggests the need for greater dissemination of its use and scope as a biomarker in IBD.

show abstract

“…Given that many patients do not feel adequately informed about the colonoscopy procedure [ 16 ], it is crucial to provide patients with materials to enhance their understanding. In a recent systematic review of enhanced education for bowel preparation (ie, counseling or training sessions, educational booklets, or videos), researchers found that enhanced education methods improve bowel preparation and promote better visualization of the colon in patients preparing for colonoscopy [ 38 ].…”

Section: Discussionmentioning

confidence: 99%

“…In 2017, our research team developed a project titled “Optimizing colonoscopy procedures and reducing unnecessary and over use” and explored the information needs and preferences of patients undergoing colonoscopy [ 16 ]. On the basis of the expressed needs and inputs from patients and health care providers, we developed revised educational resources for patients considering or preparing for colonoscopy.…”

Section: Methodsmentioning

confidence: 99%

“…Nevertheless, it is not well understood how patients perceive such information, although enhanced instructions improve the quality of bowel preparation [14]. Previous research indicates that patients and their families have several questions about colonoscopy that are not fully answered by existing resources [15][16][17]. Moreover, although several educational videos on colonoscopy are available, most of them have not been evaluated systematically.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

New Patient Education Video on Colonoscopy Preparation: Development and Evaluation Study

Bernstein

¹

,

Garber

²

,

Faucher

³

et al. 2020

Self Cite

View full text Add to dashboard Cite

Background Although several patient education materials on colonoscopy preparation exist, few studies have evaluated or compared them; hence, there is no professional consensus on recommended content or media to use. Objective This study aims to address this need by developing and evaluating a new video on colonoscopy preparation. Methods We developed a new video explaining split-dose bowel preparation for colonoscopy. Of similar content videos on the internet (n=20), the most favorably reviewed video among patient and physician advisers was used as the comparator for the study. A total of 232 individuals attending gastroenterology or urology clinics reviewed the new and comparator videos. The order of administration of the new and comparator videos was randomly counterbalanced to assess the impact of presentation order. Respondents rated each video on the following dimensions: information amount, clarity, trustworthiness, understandability, new or familiar information, reassurance, information learned, understanding from the patient’s point of view, appeal, and the likelihood of recommending the video to others. Results Overall, 71.6% (166/232) of the participants preferred the new video, 25.0% (58/232) preferred the comparator video, and 3.4% (8/232) were not sure. Furthermore, 64.0% (71/111) of those who viewed the new video first preferred it, whereas 77.7% (94/121) of the participants who viewed the new video second preferred it. Multivariable logistic regression analysis also demonstrated that participants were more likely to prefer the new video if they had viewed it second. Participants who preferred the new video rated it as clearer and more trustworthy than those who preferred the comparator video. Conclusions This study developed and assessed the strengths of a newly developed colonoscopy educational video.

show abstract

“…In addition, it is difficult to perform an endoscopic evaluation when there is injury to the intestinal mucosa, a frequent problem in IBD [17][18][19] .…”

Section: Discussionmentioning

confidence: 99%

Patient knowledge of fecal calprotectin in inflammatory bowel disease (IBD): An observational study in Mexico

Maldonado-Arriaga

¹

,

Sandoval-Jiménez

²

,

Rodrı́guez-Silverio

³

et al. 2020

F1000Res

0

View full text Add to dashboard Cite

Background: Fecal calprotectin (FC) can be a valuable tool to optimize health care for patients with inflammatory bowel disease (IBD). The objective of this observational study was to determine the level of knowledge of the FC test in Mexican patients with IBD. Methods: A self-report questionnaire was distributed via Facebook to patients with IBD. The survey consisted of 15 questions in two categories: the first category assessed knowledge of IBD diagnosis, and the second category assessed knowledge of the FC test. Results: In total, 460 patients with IBD participated, of which 83.9% (386) had ulcerative colitis (UC) and 16.0% (74) had Crohn’s disease (CD). Regarding IBD diagnosis, 41.9% of participants stated that they did not know of a non-invasive test for fecal matter to identify inflammation of the colon. Regarding the FC test, 57.5% (UC) and 58.1% (CD) stated that they did not know about the test. Additionally, 65.8% (UC) and 51.3% (CD) of participants stated that they had never received the FC test and 82.6% (UC) and 77.0% (CD) recognized that the FC test was difficult to access in their medical practice. Furthermore, 66% (UC) and 52.7% (CD) of participants noted that their specialist doctor had never suggested the FC test to them, yet 89.1% (UC) and 87.8% (CD) stated that they would prefer FC analysis for their IBD follow-up assessments. Conclusions: There is little knowledge of the FC biomarker among Mexican patients with IBD. This suggests the need for greater dissemination of its use and scope as a biomarker in IBD.

show abstract

Information experiences, needs, and preferences of colonoscopy patients

Abstract: Supplemental Digital Content is available in the text

Cited by 16 publications

References 28 publications

Patient knowledge of fecal calprotectin in inflammatory bowel disease (IBD): An observational study in Mexico

Patient knowledge of fecal calprotectin in inflammatory bowel disease (IBD): An observational study in Mexico

New Patient Education Video on Colonoscopy Preparation: Development and Evaluation Study

Patient knowledge of fecal calprotectin in inflammatory bowel disease (IBD): An observational study in Mexico

Contact Info

Product

Resources

About